Medicare Enrolled
Dr. Dina Liberman, M.D.
Allergy & Immunology (Internal Medicine) Physician · Brooklyn, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Liberman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Liberman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Liberman
Dr. Dina Liberman is an allergy & immunology physician in Brooklyn, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Liberman performed 4,911 Medicare services across 2,648 unique beneficiaries.
Between the years covered by Open Payments, Dr. Liberman received a total of $35,049 from 59 pharmaceutical and/or device companies across 937 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in allergy & immunology (internal medicine) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Liberman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 17% volume in NY
$35,049 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,911
Medicare services
Top 17% in NY for allergy & immunology (internal medicine) physician
2,648
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~246 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,137 | $85 | $150 |
| Skin allergy test A test where small amounts of potential allergens are injected into the skin to check for allergic reactions. |
464 | $8 | $15 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
432 | $7 | $12 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
353 | $85 | $150 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
219 | $13 | $50 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
208 | $1 | $5 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
182 | $95 | $250 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
154 | $152 | $250 |
| Annual alcohol misuse screening, 5 to 15 minutes | 154 | $22 | $50 |
| Annual depression screening | 154 | $22 | $50 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
146 | $54 | $75 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
134 | $40 | $100 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
104 | $14 | $50 |
| Neurobehavioral status exam, first hour A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions. |
99 | $85 | $150 |
| Obesity behavioral counseling, 15 minutes A 15-minute face-to-face session focused on behavioral counseling to help manage obesity. |
89 | $30 | $50 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
86 | $2 | $10 |
| Ketone bodies analysis, quantitative A laboratory test that measures the specific amount of ketone bodies in a sample. This procedure quantifies the levels of ketones to assess metabolic status. |
86 | $8 | $30 |
| Total bilirubin level test A blood test that measures the total amount of bilirubin, a waste product from the breakdown of red blood cells, in your body. |
86 | $5 | $10 |
| Body fluid pH level test A laboratory test that measures the acidity or alkalinity of a body fluid sample. |
86 | $4 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
80 | $119 | $200 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
59 | $375 | $500 |
| Digital analysis of brain wave activity (EEG) This procedure involves the digital analysis of brain wave activity recorded via an electroencephalogram (EEG). It focuses on the technical interpretation of the digital data rather than the initial recording or supervision. |
59 | $266 | $500 |
| Psychological or neuropsychological test, first 30 minutes Administration of psychological or neuropsychological testing for the first 30 minutes. |
58 | $40 | $80 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
43 | $1 | $5 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
37 | $63 | $150 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
36 | $1 | $5 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
32 | $149 | $250 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
31 | $53 | $100 |
| Denosumab injection (Prolia/Xgeva) | 23 | $0 | $0 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
20 | $195 | $250 |
| Respiratory virus nucleic acid test, 3-5 targets A laboratory test that uses nucleic acid detection to identify multiple types or subtypes of respiratory viruses. The test analyzes 3 to 5 specific viral targets. |
19 | $140 | $500 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 14 | $20 | $50 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
14 | $36 | $50 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
13 | $72 | $150 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.5% high complexity
12.7% medium
85.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$35,049
Total received (2018-2024)
Avg $5,007/year across 7 years
Top 14% in NY for allergy & immunology (internal medicine) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
937
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$35,049 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,853
2023
$4,888
2022
$5,351
2021
$4,192
2020
$3,302
2019
$6,805
2018
$5,657
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,536
AstraZeneca Pharmaceuticals LP
$788
GlaxoSmithKline, LLC.
$524
Amgen Inc.
$510
Lilly USA, LLC
$346
Sumitomo Pharma America, Inc.
$229
SCILEX PHARMACEUTICALS INC.
$173
Boehringer Ingelheim Pharmaceuticals, Inc.
$138
Novartis Pharmaceuticals Corporation
$136
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$109
E.R. Squibb & Sons, L.L.C.
$89
Novo Nordisk Inc
$85
IRONWOOD PHARMACEUTICALS, INC
$75
AIMMUNE THERAPEUTICS, INC.
$45
Takeda Pharmaceuticals U.S.A., Inc.
$30
Kowa Pharmaceuticals America, Inc.
$21
PFIZER INC.
$19
Top 3 companies account for 58.7% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$6,040
ABBVIE INC.
$4,444
AstraZeneca Pharmaceuticals LP
$2,826
GlaxoSmithKline, LLC.
$2,620
Amarin Pharma Inc.
$1,854
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,784
Novo Nordisk Inc
$1,529
Lilly USA, LLC
$1,399
Novartis Pharmaceuticals Corporation
$1,340
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,018
AbbVie Inc.
$970
PFIZER INC.
$792
E.R. Squibb & Sons, L.L.C.
$649
Allergan Inc.
$579
AbbVie, Inc.
$468
Kowa Pharmaceuticals America, Inc.
$466
SANOFI-AVENTIS U.S. LLC
$436
Sumitomo Pharma America, Inc.
$394
SCILEX PHARMACEUTICALS INC.
$376
Takeda Pharmaceuticals U.S.A., Inc.
$357
Merck Sharp & Dohme Corporation
$349
Allergan, Inc.
$345
BioFire Diagnostics, LLC
$342
Astellas Pharma US Inc
$327
Scilex Pharmaceuticals Inc.
$324
Nestle HealthCare Nutrition Inc.
$297
Almatica Pharma LLC
$244
Horizon Therapeutics plc
$233
Ironwood Pharmaceuticals, Inc
$220
VIVUS LLC
$180
Sunovion Pharmaceuticals Inc.
$152
Coloplast Corp
$126
Radius Health, Inc.
$125
NESTLE HEALTHCARE NUTRITION INC.
$123
Axsome Therapeutics, Inc.
$121
SK Life Science, Inc.
$116
Assertio Therapeutics, Inc.
$90
ARBOR PHARMACEUTICALS, INC.
$87
Vanda Pharmaceuticals Inc.
$85
Celgene Corporation
$84
Merck Sharp & Dohme LLC
$78
IRONWOOD PHARMACEUTICALS, INC
$75
Hikma Pharmaceuticals USA
$65
Endo Pharmaceuticals Inc.
$54
Janssen Pharmaceuticals, Inc
$53
Teva Pharmaceuticals USA, Inc.
$45
AIMMUNE THERAPEUTICS, INC.
$45
Blueprint Medicines Corporation
$43
IBSA Pharma Inc.
$42
Medtronic MiniMed, Inc.
$41
Regeneron Healthcare Solutions, Inc.
$40
VistaPharm, Inc.
$29
MannKind Corporation
$20
Cumberland Pharmaceuticals, Inc.
$20
EISAI INC.
$20
Philips Electronics North America Corporation
$18
Smith+Nephew, Inc.
$17
Horizon Pharma plc
$17
Circassia Pharmaceuticals Inc
$15
Top 3 companies account for 38.0% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · AFREZZA · AIRSUPRA · AJOVY · ALTIS · ANORO · ANORO ELLIPTA · AREXVY · Aimovig · Amitiza · Auvelity · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · BYSTOLIC · BioFire QC Material (CHEM-CTL-0001) · CAMZYOS · CHANTIX · COLOGUARD · CREON · CYLTEZO · Creon · DUPIXENT · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Edarbi · FARXIGA · GEMTESA · GRALISE · Gralise · HETLIOZ · INVOKANA · JANUVIA · JARDIANCE · KRISTALOSE · LEQVIO · LINZESS · LIVALO · LOREEV XR · Licart · Linzess · Livalo · MOTEGRITY · MOUNJARO · MOVANTIK · MYRBETRIQ · Mitigare · Motegrity · NAPRELAN · NASCOBAL · Otezla · Ozempic · PANCREAZE · PENNSAID · PRALUENT · PREMARIN · Pancreaze · Prolia · QULIPTA · REGRANEX · RELISTOR · RYBELSUS · Repatha · Rybelsus · SEGLENTIS · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Synthroid · TEPEZZA · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · TUDORZA PRESSAIR · Thyquidity · Tresiba · Tymlos · UBRELVY · UTIBRON · VIAGRA · VIBERZI · VRAYLAR · Vascepa · Victoza · XCOPRI · XIFAXAN · XIFAXANIBSD · ZENPEP · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · iPro2
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Allergy & immunology physicians within 10 mi
37
Per 100K population
1.4
County median income
$78,548
Nearest hospital
SOUTH BROOKLYN HEALTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Liberman is a clinical cardiology specialist, with above-average Medicare volume (top 17% in NY), with low-engagement industry engagement in the top 14% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Liberman experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Liberman performed 1,137 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Liberman receive payments from pharmaceutical companies?
Yes. Dr. Liberman received a total of $35,049 from 59 companies across 937 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Liberman's costs compare to other allergy & immunology physicians in Brooklyn?
Dr. Liberman's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Liberman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Allergy & Immunology Physicians in Brooklyn
Browse allergy & immunology physicians in Brooklyn ranked by procedure volume and transparency data.
Highest volume
Top Allergy & Immunology Physicians in NY
Allergy & immunology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Allergy & Immunology Physicians in NY
Which NY allergy & immunology physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology